PIXELCELL PTE.LIMITED – Trademark Portfolio
Entity Type: 99
PIXELCELL PTE.LIMITED holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 16 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 12 trademarks are registered and 2 are pending. Notable registered marks include XROOM, SEWPAL, BEVOCAL, GRADEUP, and MINDBUD. The owner is based in SINGAPORE.
ROYAL GROUP BUILDING
3 PHILLIP STREET#09-02
SINGAPORE 048693 , SG
Showing of trademarks Trademarks
Trademark Classifications
PIXELCELL PTE.LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does PIXELCELL PTE.LIMITED have?
PIXELCELL PTE.LIMITED has 17 U.S. trademarks filed with the USPTO. Of these, 12 registered, 2 pending, 3 abandoned.
What trademark classes does PIXELCELL PTE.LIMITED file in?
PIXELCELL PTE.LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are PIXELCELL PTE.LIMITED's most well-known trademarks?
PIXELCELL PTE.LIMITED's registered trademark portfolio includes well-known marks such as XROOM, SEWPAL, BEVOCAL, GRADEUP, and MINDBUD. These are among 12 currently registered trademarks in the portfolio.
What is PIXELCELL PTE.LIMITED's trademark registration success rate?
PIXELCELL PTE.LIMITED has a 80% trademark registration rate, with 12 out of 15 resolved applications resulting in successful registration. Currently, 2 applications are pending review.